| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 46.91B | 60.60B | 59.74B | 46.78B | 36.93B | 37.69B |
| Gross Profit | 46.91B | 43.84B | 43.09B | 38.18B | 35.45B | 35.55B |
| EBITDA | 5.99B | 9.41B | 8.76B | 9.99B | 10.48B | 9.48B |
| Net Income | 5.80B | 5.71B | 5.05B | 5.39B | 5.78B | 5.45B |
Balance Sheet | ||||||
| Total Assets | 2.84T | 2.96T | 2.89T | 2.89T | 2.89T | 2.77T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 269.08B | 204.90B | 218.00B | 339.77B | 286.27B |
| Total Debt | 66.57B | 71.00B | 72.74B | 95.58B | 128.39B | 78.16B |
| Total Liabilities | 2.71T | 2.83T | 2.75T | 2.76T | 2.75T | 2.61T |
| Stockholders Equity | 138.57B | 135.45B | 137.16B | 127.54B | 134.69B | 153.50B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 0.00 | -15.28B | -76.84B | 82.33B | 37.91B |
| Operating Cash Flow | 0.00 | 0.00 | -24.97B | -74.62B | 84.61B | 38.90B |
| Investing Cash Flow | 0.00 | 20.82B | 13.02B | -45.95B | -24.34B | -39.45B |
| Financing Cash Flow | 0.00 | 55.73B | -1.29B | -1.17B | -7.03B | -4.69B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥105.19B | 1.54 | ― | 3.05% | 39.01% | 131.93% | |
75 Outperform | ¥168.77B | 7.55 | ― | 2.29% | 10.13% | 38.83% | |
69 Neutral | ¥69.39B | 6.31 | ― | 2.34% | 1.06% | 46.07% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | ¥914.52B | 8.76 | ― | 2.10% | 2.96% | 39.35% | |
65 Neutral | ¥245.85B | 10.90 | ― | 2.53% | 11.64% | 28.24% | |
65 Neutral | ¥10.82B | 8.64 | ― | 2.74% | 14.07% | -99.32% |